Women & Infants Hospital
Providence, Rhode Island, 02905, United States
NCT Number: NCT05399784
The objective of this study is to assess if the addition of an early postpartum visit improves attendance at postpartum visits. We seek to evaluate if an additional early postpartum visit improves patient education, satisfaction, or trust in the clinicians during the postpartum period; all of which may ultimately facilitate improved outcomes. Additionally, we seek to explore patient preferences for postpartum care delivery.
Looking for future studies?
Notify Me13 year–50 year
Female
Interventional
Not applicable
Providence, Rhode Island, 02905, United States
Maternal mortality in the United States is currently at a record high of 17 deaths per 100,000 live births and the majority of pregnancy related deaths occur in the postpartum period due to complications from chronic disease exacerbation, pregnancy-related hypertension, or psychiatric conditions that lead to suicide. Optimal postpartum care would reduce mortality risk, but numerous studies have demonstrated current care is inadequate. Up to 40% of women do not attend their postpartum visit at 4-6 weeks after delivery and the 15-minute visit is too short to achieve the comprehensive goals that the American College of Obstetricians and Gynecologists (ACOG) sets for this visit: a full assessment of physical, social, and psychological well-being. In addressing the current gap between optimal and actual care, ACOG recently recommended that practitioners shift from the standard, single six-week postpartum visit to two postpartum visits, the first within three weeks of delivery. While this change is intended to address current sub-optimal outcomes, the effects of this change are entirely unknown.
The long term goal of our program is to improve postpartum care for women in Rhode Island. The primary objective of this project is to determine if the ACOG proposed additional postpartum visit within three weeks of delivery improves attendance to postpartum appointments compared to routine postpartum care. Additionally, we intend to examine whether having two scheduled postpartum visits (one within three weeks and the other at the standard 4-6 week postpartum time point) which we describe as "early and often" postpartum care-improves patient knowledge, satisfaction and trust in clinicians compared to routine care as well as explore patient preferences for postpartum care. Our central hypothesis is that early and often postpartum care will lead to improved patient visit attendance compared to routine care.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
High risk pregnancy defined as one or more of the following:
The early postpartum visit will be an in-person visit with a medical provider at 14-21 days postpartum.
The standard postpartum visit will occur at 35 to 56 days postpartum.
Time frame: 3 months
The number of times a patient attends a postpartum visit in the first 12 weeks postpartum will be counted
Time frame: 3 months
Patients will complete a survey (created for this study) and identify how many key postpartum items were discussed during their postpartum care.
Time frame: 3 months
The Trust in Physicians scale is a reliable and valid measure of a patients trust in their clinician and has been shown to be distinct from patient satisfaction
Time frame: 3 months
The Short Assessment of Patient Satisfaction (SAPS) is a short, reliable, valid, seven item scale to assess patients satisfaction with medical treatment and care
Time frame: 3 months
Emergency room utilization will be determined via the electronic medical record. The number of visits in the first 3 months postpartum will be recorded.
Women and Infants Hospital of Rhode Island
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05382884
Depression, Postpartum, Depressive Disorder
Vancouver, British Columbia, Canada
View Trial DetailsNCT05225987
Depression, Postpartum, Depressive Disorder
Ankara, Turkey (Türkiye)
View Trial DetailsNCT05676918
Depression, Postpartum, Depressive Disorder
Madrid, Pozuelo de Alarcón, Spain
View Trial DetailsNCT06164301
Behavior, Critical Illness
Cairo, Cairo Governorate, Egypt
View Trial Details